Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos

Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration ­4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (­0.004-0.12), for SPNI was 0.03 µg/ml (­0.004-025), for SPNR was 0.06 µg/ml (­0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (­0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections

Saved in:
Bibliographic Details
Main Authors: Ulloa F,María T, Camponovo C,Rossanna, Fernández V,Alejandra, García C,Patricia, Prado J,Valeria, González A,Patricia, Rojas S,Pamela, Inostroza S,Jaime, Lafourcade R,Mónica, Aguilera A,Liliana, Porte T,Lorena, Cruz P,Carolina, Joyas M,Alejandro, Alcaide L,Berta, Pinto C,María E, Giglio M,María S
Format: Digital revista
Language:Spanish / Castilian
Published: Sociedad Médica de Santiago 2005
Online Access:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000400004
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-98872005000400004
record_format ojs
spelling oai:scielo:S0034-988720050004000042005-06-13Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenosUlloa F,María TCamponovo C,RossannaFernández V,AlejandraGarcía C,PatriciaPrado J,ValeriaGonzález A,PatriciaRojas S,PamelaInostroza S,JaimeLafourcade R,MónicaAguilera A,LilianaPorte T,LorenaCruz P,CarolinaJoyas M,AlejandroAlcaide L,BertaPinto C,María EGiglio M,María S Bacterial sensitivity tests Ketolides Respiratory tract infections Telithromycin Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration ­4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (­0.004-0.12), for SPNI was 0.03 µg/ml (­0.004-025), for SPNR was 0.06 µg/ml (­0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (­0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infectionsinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.133 n.4 20052005-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000400004es10.4067/S0034-98872005000400004
institution SCIELO
collection OJS
country Chile
countrycode CL
component Revista
access En linea
databasecode rev-scielo-cl
tag revista
region America del Sur
libraryname SciELO
language Spanish / Castilian
format Digital
author Ulloa F,María T
Camponovo C,Rossanna
Fernández V,Alejandra
García C,Patricia
Prado J,Valeria
González A,Patricia
Rojas S,Pamela
Inostroza S,Jaime
Lafourcade R,Mónica
Aguilera A,Liliana
Porte T,Lorena
Cruz P,Carolina
Joyas M,Alejandro
Alcaide L,Berta
Pinto C,María E
Giglio M,María S
spellingShingle Ulloa F,María T
Camponovo C,Rossanna
Fernández V,Alejandra
García C,Patricia
Prado J,Valeria
González A,Patricia
Rojas S,Pamela
Inostroza S,Jaime
Lafourcade R,Mónica
Aguilera A,Liliana
Porte T,Lorena
Cruz P,Carolina
Joyas M,Alejandro
Alcaide L,Berta
Pinto C,María E
Giglio M,María S
Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
author_facet Ulloa F,María T
Camponovo C,Rossanna
Fernández V,Alejandra
García C,Patricia
Prado J,Valeria
González A,Patricia
Rojas S,Pamela
Inostroza S,Jaime
Lafourcade R,Mónica
Aguilera A,Liliana
Porte T,Lorena
Cruz P,Carolina
Joyas M,Alejandro
Alcaide L,Berta
Pinto C,María E
Giglio M,María S
author_sort Ulloa F,María T
title Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
title_short Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
title_full Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
title_fullStr Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
title_full_unstemmed Estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
title_sort estudio de la actividad comparativa in vitro de telitromicina en patógenos respiratorios adquiridos en la comunidad en 13 centros clínicos chilenos
description Background: Telithromycin is a new ketolide antimicrobial, that can be useful for the treatment of respiratory infections. Aim: To compare in vitro activity of telithromycin against respiratory pathogens, isolated in outpatient clinics. Material and methods: Two hundred eighty strains isolated from patients with respiratory infections, were studied. The strains studied were S pneumoniae, penicillin sensitive (SPNS:57); intermediate (SPNI:35), resistant (SPNR:25); S pyogenes (SP:57); H influenzae (HIN 51); M catarrhalis (MC:25) and S aureus meticillin sensitive (SAUS:30). Minimal inhibitory concentration (MIC) by broth microdilution was studied for telitrhomycin and levofloxacin in all strains. Other antimicrobials studied, but not in all strains were erythromycin, clindamycin, trimetoprim sulphamethoxazole, oxacillin, amoxicillin-clavulanic acid and cefuroxime. Results: All strains were sensible to telithromycin at a concentration ­4 µg/ml. MIC 90 and its range for SPNS was 0.03 µg/ml (­0.004-0.12), for SPNI was 0.03 µg/ml (­0.004-025), for SPNR was 0.06 µg/ml (­0.004-0.25), for HIN was 2 µg/ml (0.12-4), for SP was 0.5 µg/ml (­0.004-2), for MC was 0.5 µg/ml (0.06-2) and for SAU was 0.25 µg/ml (0.06-0.25). Conclusions: All studied pathogens were sensible to telithromycin in vitro. This antimicrobial is an alternative for the treatment of community acquired respiratory infections
publisher Sociedad Médica de Santiago
publishDate 2005
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000400004
work_keys_str_mv AT ulloafmariat estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT camponovocrossanna estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT fernandezvalejandra estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT garciacpatricia estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT pradojvaleria estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT gonzalezapatricia estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT rojasspamela estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT inostrozasjaime estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT lafourcadermonica estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT aguileraaliliana estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT portetlorena estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT cruzpcarolina estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT joyasmalejandro estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT alcaidelberta estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT pintocmariae estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
AT gigliommarias estudiodelaactividadcomparativainvitrodetelitromicinaenpatogenosrespiratoriosadquiridosenlacomunidaden13centrosclinicoschilenos
_version_ 1755988158970855424